Evidence map›Paper›PMID 36105174›Full record

ArticleFrontiers in oral health2022

Metronidazole enhances killing of

Mihaela Anca Serbanescu, Morvarid Oveisi, Chunxiang Sun, Noah Fine, Anne Bosy, Michael Glogauer

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oral health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Cancers · 2025
    Review
  4. Article
  5. Article
  6. Metronidazole Potentiation by Panax Ginseng andAntibiotics (Basel, Switzerland) · 2023
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Mihaela Anca SerbanescuFaculty of Dentistry, University of Toronto, Toronto, ON, Canada.
Morvarid OveisiFaculty of Dentistry, University of Toronto, Toronto, ON, Canada.
Chunxiang SunFaculty of Dentistry, University of Toronto, Toronto, ON, Canada.
Noah FineFaculty of Dentistry, University of Toronto, Toronto, ON, Canada.
Anne BosyOraVital Inc., Toronto, ON, Canada.
Michael GlogauerFaculty of Dentistry, University of Toronto, Toronto, ON, Canada.
University of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and objectives: Periodontitis affects the supporting structures of the teeth as a result of the interactions between the subgingival biofilm and the host immune system. Periodontal therapy in severe forms of periodontitis often utilizes antimicrobial agents with some potential to improve host defense responses. In the present study, we investigated the Materials and methods: Flow cytometry based assays were used to measure the impact of MTZ on PMN degranulation, neutrophil extracellular trap (NET) formation and myeloperoxidase (MPO) release and phagocytosis in response to the keystone oral pathogen Results: We demonstrate that PMNs pretreated with MTZ (2 μg/ml or 50 μg/ml) displayed enhanced killing of Conclusion: MTZ displays a positive interaction with PMNs to potentiate PMN mediated killing of

Indexed as

anti-infective agentsmetronidazoleneutrophils (PMNs)periodontitisPorphyromonas gingivalis

Identifiers

PMID36105174
PMCPMC9464935
OpenAlexW4293421063

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.